WATSON LABS INC FDA Approval ANDA 063008

ANDA 063008

WATSON LABS INC

FDA Drug Application

Application #063008

Application Sponsors

ANDA 063008WATSON LABS INC

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 10GM BASE/VIAL0NAFCILLIN SODIUMNAFCILLIN SODIUM

FDA Submissions

ORIG1AP1988-09-29
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1988-12-07
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1990-11-07
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1993-02-16
LABELING; LabelingSUPPL6AP1994-03-18
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1993-11-19
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1994-01-13
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1995-01-27
LABELING; LabelingSUPPL11AP1996-03-22
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1995-12-15
LABELING; LabelingSUPPL13AP1997-07-16
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1997-12-29
MANUF (CMC); Manufacturing (CMC)SUPPL18AP2000-12-08

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL5Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0
SUPPL12Null0
SUPPL15Null0
SUPPL18Null0

CDER Filings

WATSON LABS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 63008
            [companyName] => WATSON LABS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"NAFCILLIN SODIUM","activeIngredients":"NAFCILLIN SODIUM","strength":"EQ 10GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NAFCILLIN SODIUM","submission":"NAFCILLIN SODIUM","actionType":"EQ 10GM BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.